The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines
Open accessAbstract
The Histiocytoses are defined as non-malignant disorders due to abnormal accumulation and behavior of cells of the mononuclear phagocytic system. The best known histiocytoses, Langerhans cell histiocytosis (LCH), and hemophagocytic lymphohistiocytosis (HLH), each with an estimated incidence of 1/50,000 to 1/150,000, are sufficiently "common," complex and costly, to constitute an important problem in medical practice. At the same time, LCH, HLH and an array of other and more rare histiocytoses are sufficiently uncommon that most physicians lack the experience to diagnose, let alone care for patients with these conditions. The pathophysiology of most of the histiocytoses is unknown and, in the case of the widely-disseminated and potentially fatal forms, treatments to date have been variably effective and sometimes highly toxic. MAS has been reported to occur in association with almost any rheumatic disease, it is by far most common in the systemic form of Juvenile Idiopthic Arthritis (SoJIA). It is now recognized that MAS bears a close resemblance to Hemophagocytic Lymphohistiocytosis or HLH, and MAS is recognized as the major fatal complication of soJIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Self-citationPerforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Certain, S., Mathew, P. A., Henter, J.-I., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,241
Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachée-Chardin, M., Chedeville, G., Tamary, H., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00855-9 · Cited by 943
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
Rigaud, S., Fondanèche, M.-C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F., Rieux-Laucat, F., Revy, P., et al. (2006) · Nature · doi:10.1038/nature05257 · Cited by 706
Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis
Allen, C. E., Yu, X., Kozinetz, C. A., & McClain, K. L. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21423 · Cited by 634
Self-citationzur Stadt, U. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi076 · Cited by 562
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
Sawhney, S. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.5.421 · Cited by 467
zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauß, J., Kasper, B., Nürnberg, G., Becker, C., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.005 · Cited by 427
Stephan, J. L. (2001) · Rheumatology · doi:10.1093/rheumatology/40.11.1285 · Cited by 327
Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321
Self-citationGrom, A. A., Villanueva, J., Lee, S., Goldmuntz, E. A., Passo, M. H., & Filipovich, A. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.110 · Cited by 284
Self-citationMouy, R., Stephan, J.-L., Pillet, P., Haddad, E., Hubert, P., & Prieur, A.-M. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70160-9 · Cited by 244
Villanueva, J., Lee, S., Giannini, E. H., Graham, T. B., Passo, M. H., Filipovich, A., & Grom, A. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1453 · Cited by 243
Self-citationHaematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
Horne, A., Janka, G., Maarten Egeler, R., Gadner, H., Imashuku, S., Ladisch, S., Locatelli, F., Montgomery, S. M., Webb, D., Winiarski, J., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05501.x · Cited by 235
Self-citationElevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes
Komp, D., McNamara, J., & Buckley, P. (1989) · Blood · doi:10.1182/blood.v73.8.2128.2128 · Cited by 230
Grom, A. A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20198 · Cited by 208
Self-citationStem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis
Cooper, N., Rao, K., Gilmour, K., Hadad, L., Adams, S., Cale, C., Davies, G., Webb, D., Veys, P., & Amrolia, P. (2006) · Blood · doi:10.1182/blood-2005-05-1819 · Cited by 189
Zhang, K., Biroschak, J., Glass, D. N., Thompson, S. D., Finkel, T., Passo, M. H., Binstadt, B. A., Filipovich, A., & Grom, A. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23734 · Cited by 182
Self-citationSnow, A. L., Marsh, R. A., Krummey, S. M., Roehrs, P., Young, L. R., Zhang, K., van Hoff, J., Dhar, D., Nichols, K. E., Filipovich, A. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39518 · Cited by 164
Self-citationBrinkman, D. M. C., de Kleer, I. M., Cate, R. T., van Rossum, M. A. J., Bekkering, W. P., Fasth, A. L., van Tol, M. J. D., Kuis, W., Wulffraat, N. M., & Vossen, J. M. J. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22656 · Cited by 144
Balamuth, N., Nichols, K. E., Paessler, M. E., & Teachey, D. T. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3180f61be3 · Cited by 121
Ohga, S., Kudo, K., Ishii, E., Honjo, S., Morimoto, A., Osugi, Y., Sawada, A., Inoue, M., Tabuchi, K., Suzuki, N., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22310 · Cited by 121
Hazen, M. M., Woodward, A., Hofmann, I., Degar, B. A., Grom, A. A., Filipovich, A. H., & Binstadt, B. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23199 · Cited by 112
Self-citationConsumption coagulopathy associated with systemic juvenile rheumatoid arthritis
Silverman, E. D., Miller, J. J., Bernstein, B., & Shafai, T. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80704-5 · Cited by 101
Pattern and Course of Neurodegeneration in Langerhans Cell Histiocytosis
Wnorowski, M., Prosch, H., Prayer, D., Janßen, G., Gadner, H., & Grois, N. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.12.042 · Cited by 96
Allen, C. E., Flores, R. J., Rauch, R. A., Dauser, R., Murray, J. C., Puccetti, D., Hsu, D., Sondel, P. M., Hetherington, M. L., Goldman, S., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22326 · Cited by 96
Self-citationThe soluble interleukin‐2 receptor in rheumatic disease
Rubin, L. A. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330814 · Cited by 43
Anti‐CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis
Jordan, M. B., McClain, K. L., Yan, X., et al. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20181 · Cited by 42
Self-citationMacrophage activation syndrome and other systemic inflammatory conditions after BMT
Sreedharan, A., Bowyer, S. L., Wallace, C. A., Robertson, M. J., Schmidt, K. M., Woolfrey, A. E., & NELSON, R. P. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705305 · Cited by 42
Cited by
Recurrent BRAF mutations in Langerhans cell histiocytosis
Badalian-Very, G., Vergilio, J.-A., Degar, B. A., MacConaill, L. E., Brandner, B., Calicchio, M. L., Kuo, F. C., Ligon, A. H., Stevenson, K. E., Kehoe, S. M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279083 · Cited by 1,243
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Copaescu, A., Smibert, O., Gibson, A., Phillips, E. J., & Trubiano, J. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.001 · Cited by 262
Metadata
- Authors
- Filipovich, A., McClain, K., & Grom, A.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 16
- Issue
- 1
- Pages
- S82-S89
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2004442541
- Cited by
- 294
- References
- 29
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.